Dr Schmid has had a prominent career in the field of biotechnology and aerosol physics, and his research has included the development of the ALICE-CLOUD technology to enable rapid delivery of aerosolized drugs to cells at air-liquid interface conditions. Dr Schmid also conducts preclinical in-vitro and in-vivo studies investigating both therapeutic and toxicological effects of aerosolized substances including experimental drugs, nanomaterials, and cigarette smoke in the lung.